2023 article
Age-associated changes in electroretinography measures in companion dogs
Salzman, M. M., Merten, N., Panek, W. K., Fefer, G., Mondino, A., Westermeyer, H. D., … Mowat, F. M. (2023, June 11). DOCUMENTA OPHTHALMOLOGICA, Vol. 6.
2023 journal article
Winning the race with aging: age-related changes in gait speed and its association with cognitive performance in dogs
FRONTIERS IN VETERINARY SCIENCE, 10.
2022 article
Relationship between hearing, cognitive function, and quality of life in aging companion dogs
Fefer, G., Khan, M. Z., Panek, W. K., Case, B., Gruen, M. E., & Olby, N. J. (2022, August 6). JOURNAL OF VETERINARY INTERNAL MEDICINE, Vol. 8.
2022 journal article
Use of Cognitive Testing, Questionnaires, and Plasma Biomarkers to Quantify Cognitive Impairment in an Aging Pet Dog Population
JOURNAL OF ALZHEIMERS DISEASE, 87(3), 1367–1378.
2021 journal article
Computed tomography findings in a cohort of 169 dogs with elbow dysplasia-a retrospective study
BMC VETERINARY RESEARCH, 17(1).
Contributors: M. Hebel *, n , J. Ruszkowski *, M. Nabzdyk *, D. Niedzielski*, K. Pituch*, A. Jackson, M. Kiełbowicz*, M. Pomorska-Mól *
2020 journal article
BET inhibition increases βIII-tubulin expression and sensitizes metastatic breast cancer in the brain to vinorelbine
Science Translational Medicine, 12(558).
Contributors: D. Kanojia *, * , A. Cordero *, J. Fares *, A. Xiao *, S. Savchuk *, K. Kumar *, T. Xiao *
2020 journal article
Plasma Amyloid Beta Concentrations in Aged and Cognitively Impaired Pet Dogs
MOLECULAR NEUROBIOLOGY, 58(2), 483–489.
Contributors: , D. Murdoch *, M. Gruen n , F. Mowat n, R. Marek * & N. Olby n n
2020 journal article
Plasma Neurofilament Light Chain as a Translational Biomarker of Aging and Neurodegeneration in Dogs
MOLECULAR NEUROBIOLOGY, 57(7), 3143–3149.
Contributors: , M. Gruen n , D. Murdoch *, R. Marek *, A. Stachel n, F. Mowat*, K. Saker n, N. Olby n n
2019 journal article
FABP7 is a key metabolic regulator in HER2+ breast cancer brain metastasis
Oncogene, 38(37), 6445–6460.
Contributors: A. Cordero *, D. Kanojia *, J. Miska *, * , A. Xiao *, Y. Han *, N. Bonamici*, W. Zhou *
2019 journal article
GCN2 is essential for CD8<sup>+</sup> T cell survival and function in murine models of malignant glioma
Cancer Immunology, Immunotherapy, 69(1), 81–94.
Contributors: A. Rashidi *, J. Miska *, C. Lee-Chang *, D. Kanojia *, * , A. Lopez-Rosas *, P. Zhang *, Y. Han *
2019 journal article
HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
Cell Reports, 27(1), 226–237.e4.
Contributors: J. Miska *, C. Lee-Chang *, A. Rashidi *, M. Muroski*, A. Chang *, A. Lopez-Rosas *, P. Zhang *, *
2019 journal article
Therapeutic targeting of tumor-associated myeloid cells synergizes with radiation therapy for glioblastoma
Proceedings of the National Academy of Sciences of the United States of America, 116(47), 23714–23723.
Contributors: P. Zhang *, J. Miska *, C. Lee-Chang *, A. Rashidi *, * , S. An*, M. Zannikou, A. Lopez-Rosas *
2018 journal article
A Dendritic Cell-Targeted Adenoviral Vector Facilitates Adaptive Immune Response Against Human Glioma Antigen (CMV-IE) and Prolongs Survival in a Human Glioma Tumor Model
Neurotherapeutics, 15(4), 1127–1138.
Contributors: J. Kim*, J. Kane *, * , J. Young *, A. Rashidi *, D. Yu *, D. Kanojia *, T. Hasan *
2018 journal article
Adoptive Transfer of IL13Rα2-Specific Chimeric Antigen Receptor T Cells Creates a Pro-inflammatory Environment in Glioblastoma
Molecular Therapy, 26(4), 986–995.
Contributors: K. Pituch*, J. Miska *, G. Krenciute *, * , G. Li*, T. Rodriguez-Cruz*, M. Wu*, Y. Han *
2018 chapter
Gene/Viral Treatment Approaches for Malignant Brain Cancer
In Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy: Second Edition (pp. 211–227).
Contributors: J. Kim*, K. Pituch*, A. Xiao *, J. Young *, * , M. Muroski*, A. Rashidi *, J. Kane *, D. Kanojia *, M. Lesniak *
2018 journal article
Local Application of Autologous Platelet-Rich Fibrin Patch (PRF-P) Suppresses Regulatory T Cell Recruitment in a Murine Glioma Model
Molecular Neurobiology, 56(7), 5032–5040.
Contributors: , K. Pituch*, J. Miska *, J. Kim*, A. Rashidi *, D. Kanojia *, A. Lopez-Rosas *, Y. Han * *
2017 journal article
A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
Molecular Therapy - Oncolytics, 5, 97–104.
Contributors: J. Kim*, J. Miska *, J. Young *, A. Rashidi *, J. Kane *, * , D. Kanojia *, Y. Han *, I. Balyasnikova *, M. Lesniak *
2017 journal article
Hitting the nail on the head: Combining oncolytic adenovirusmediated virotherapy and immunomodulation for the treatment of glioma
Oncotarget, 8(51), 89391–89405.
Contributors: , J. Kane *, J. Young *, A. Rashidi *, J. Kim*, D. Kanojia *, M. Lesniak * *
2017 journal article
Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression
Proceedings of the National Academy of Sciences of the United States of America, 114(30), E6147–E6156.
2017 journal article
Multiplexed nanomedicine for brain tumors: Nanosized Hercules to tame our Lernaean Hydra inside?
Nanomedicine, 12(20), 2435–2439.
Contributors: , O. Khan *, D. Yu * & M. Lesniak * *
Updated: November 14th, 2023 14:43
2023 - present
2020 - 2023
Citation Index includes data from a number of different sources. If you have questions about the sources of data in the Citation Index or need a set of data which is free to re-distribute, please contact us.
Certain data included herein are derived from the Web of Science© and InCites© (2024) of Clarivate Analytics. All rights reserved. You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.